Early gastric cancer
Conditions
Interventions
Before endoscopic submucosal dissection, 20 mg/m2 of 5-aminolevulinic acid solution was given orally. After tumor resection, resected specimens were investigated by an endoscopic phododynamic diagnosi
Sponsors
Kochi Medical School
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. An age of 20 years and over. 2. Histologically proven intestinal type gastric adenocarcinoma including papillary, well and moderate differentiated adenocarcinoma. 3. A performance status of 0-1 accord ing to the Eastern Cooperative Oncol ogy Group (ECOG) scale. 4. Adequate organ function including heart, lung, liver, kidney and bone marrow function in addition to clinical laboratory results. 5. Patients without synchronous or metachronous malignant disease, or multicentric cancer. 6. All patients gave written informed consent. 9. All patients gave written
Exclusion criteria
Exclusion criteria: 1. Uncontrollable infectious disease including active tuberculosis. 2. Serious concurrent disease such as malignant hypertension, severe congestive heart failure, severe coronary ischemic disease, acute myocardial infarction, terminal liver cirrhosis, severe renal insufficiency, dialysis patients, uncontrollable diabetes mellitus, severe pulmonary fibrosis, interstitial pneumonia and so on. 3. Patients received bone marrow transplantation. 4. Patients with psychosomatic disorder. 5. Patients with porphyria or hypersensitivity to porphyrins allergy. 6. Women who are pregnant or hope to become pregnant during the study period. 7. Patients judged inappropriate for t he study by their physicians.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Diagnostic accuracy | — |
Secondary
| Measure | Time frame |
|---|---|
| Adverse events | — |
Countries
Japan
Contacts
Public ContactTsutomu Namikawa Tsutomu Namikawa
Kochi Medical School Department of Surgery
Outcome results
None listed